CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 4 Shares withheld for taxes SVP & General Counsel gave up 26,941 shares (to pay taxes)
- 4 Open-market buy President and CEO bought 10,000 shares at $4.76 ($47,600)
- 4 Open-market buy President and CEO bought 10,000 shares at $4.76 ($47,600)
- 4 Open-market buy President and CEO bought 10,000 shares at an average $4.77 ($47,650)
- 4 Open-market buy President and CEO bought 10,000 shares at $4.46 ($44,640)
- 4 Open-market buy SVP, CFO & Treasurer bought 2,000 shares at $4.39 ($8,779)
- 4 Grant or award SVP, Chief Marketing Officer acquired 125,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 450,000 shares (grant or award)
- 4 Grant or award SVP, CFO & Treasurer acquired 125,000 shares (grant or award)
- 4 Grant or award SVP, Business Development acquired 125,000 shares (grant or award)
- 4 Grant or award SVP & General Counsel acquired 125,000 shares (grant or award)
- 4 Open-market sale Director sold 5,000 shares at $5.17 ($25,863)
- 4 Open-market sale SVP, CFO & Treasurer sold 2,251 shares at $5.92 ($13,327)
- 4 Grant or award Director acquired 21,887 shares (grant or award)
- 4 Grant or award Director acquired 20,529 shares (grant or award)
- 4 Grant or award Director acquired 20,529 shares (grant or award)
- 4 Grant or award Director acquired 20,529 shares (grant or award)
- 4 Grant or award Director acquired 20,529 shares (grant or award)
- 4 Open-market sale SVP & General Counsel sold 17,088 shares at an average $4.29 ($73,313)
- 4 Open-market sale SVP, Chief Marketing Officer sold 16,727 shares at an average $4.30 ($71,921)
Page 3 of 29 · 579 filings